Year archive

Innate Pharma — 2010 filings

All 41 regulatory filings released by Innate Pharma (IPH) in 2010, sourced directly from the official regulator.

41 Filings

2010 Period

2010 filings (41)

Filing	Released	Lang
Innate Pharma SA (Euronext Paris : FR0010331421 – IPH) annonce son calendrier financier prévisionnel pour l’année 2011 Report Publication Announcement	2010-12-22	French
Innate Pharma (Euronext Paris: FR0010331421 – IPH) announces its tentative financial calendar for 2011 Report Publication Announcement	2010-12-22	English
Innate Pharma SA (la « Société » - Euronext Paris : FR0010331421 – IPH) annonce l’inclusion d’un premier patient dans un nouvel essai clinique de Phase II multicentrique avec IPH 2101, son anticorps m Regulatory Filings	2010-11-23	French
Innate Pharma (the “Company” - Euronext Paris: FR0010331421 – IPH) announces today that it has started patient inclusion in a new multicenter Phase II clinical trial with anti-KIR monoclonal antibody Regulatory Filings	2010-11-23	English
Innate Pharma SA (Euronext Paris : FR0010331421 – IPH) annonce sa participation au « Life Sciences Day », conférence organisée par NYSE-Euronext et France Biotech, qui se tiendra au palais de la Bours Investor Presentation	2010-11-05	French
Innate Pharma (Euronext Paris: FR0010331421 – IPH) announces today that it will participate to the “Life Science Day”, a conference organized by NYSE-Euronext and France Biotech. This day will take pl Investor Presentation	2010-11-05	English
Innate Pharma SA (Euronext Paris : FR0010331421 – IPH) annonce son chiffre d’affaires pour la période du 1er janvier au 30 septembre 2010 et fait le point sur sa trésorerie Earnings Release 9M 2010	2010-11-05	French
Innate Pharma (Euronext Paris: FR0010331421 – IPH) announces its turnover for the first nine months of 2010 and updates on its cash situation Earnings Release 9M 2010	2010-11-05	English
Innate Pharma SA (Euronext Paris: FR0010331421 – IPH) annonce aujourd’hui ses résultats semestriels au 30 juin 2010. Interim / Quarterly Report H1 2010	2010-08-31	French
Innate Pharma SA (Euronext Paris: FR0010331421 – IPH) announces today its financial results for the first half of 2010. Interim / Quarterly Report H1 2010	2010-08-31	English
Rapport financier semestriel au 30 juin 2010 Interim / Quarterly Report H1 2010	2010-08-31	French
Interim Financial Report June 30, 2010 Interim / Quarterly Report H1 2010	2010-08-31	English
Bilan semestriel du contrat de liquidité INNATE PHARMA avec NATIXIS SECURITIES Capital/Financing Update	2010-07-21	French
Hlaf-year report on Innate Pharma's liquidity contract with Natixis Securities Capital/Financing Update	2010-07-21	English
Innate Pharma SA (Euronext Paris: FR0010331421 – IPH) annonce aujourd’hui les données finales de taux de réponse pour l’essai de Phase II avec IPH 1101 dans le lymphome folliculaire présentées au co Earnings Release Q2 2010	2010-06-13	French
Innate Pharma (Euronext Paris: FR0010331421 – IPH) reports today final data on response rate for the Phase II trial with IPH 1101 in follicular Non-Hodgkin’s Lymphoma reported at the EHA meeting Legal Proceedings Report	2010-06-13	English
Innate Pharma SA (Euronext Paris : FR0010331421 – IPH) annonce sa participation à deux prochains congrès médicaux majeurs Regulatory Filings	2010-06-03	French
Innate Pharma (Euronext Paris: FR0010331421 – IPH) announces it participation to major upcoming medical meetings Regulatory Filings	2010-06-03	English
Innate Pharma SA (Euronext Paris : FR0010331421 – IPH) annonce le résultat des votes de son assemblée générale ainsi que des changements dans la composition de ses organes d’administration AGM Information	2010-05-26	French
Innate Pharma (Euronext Paris: FR0010331421 – IPH) announces the outcome of its annual general meeting, as well as changes in the composition of its management and governance bodies AGM Information	2010-05-26	English
Innate Pharma SA publie le nombre d’actions composant son capital social ainsi que le nombre de droits de vote associés au 30 avril 2010 Share Issue/Capital Change	2010-05-10	French
Innate Pharma SA (Euronext Paris: FR0010331421 – IPH) releases its total number of shares outstanding as well as its voting rights as at April 30, 2010 Share Issue/Capital Change	2010-05-10	English
Innate Pharma SA (Euronext Paris : FR0010331421 – IPH) annonce son chiffre d’affaires trimestriel au 31 mars 2010 et fait le point sur sa trésorerie Earnings Release Q1 2010	2010-05-05	French
Innate Pharma (Euronext Paris: FR0010331421 – IPH) announces its turnover for the first quarter of 2010 and updates on its cash situation Earnings Release Q1 2010	2010-05-05	English
DOCUMENT DE REFERENCE ET RAPPORT FINANCIER ANNUEL, INNATE PHARMA SA Annual Report FY 2009	2010-04-29	French
Innate Pharma (Euronext Paris : FR0010331421 – IPH) annonce la mise à disposition de son Document de Référence et de son Rapport Annuel 2009 Report Publication Announcement	2010-04-29	French
Innate Pharma (Euronext Paris: FR0010331421 – IPH) announces that the French version of the 2009 Reference Document, including the Annual Financial Report, as well as the 2009 Annual Report of the Com Report Publication Announcement	2010-04-29	English
Innate Pharma (Euronext Paris : FR0010331421 – IPH) annonce la tenue de son assemblée générale annuelle le 25 mai prochain à Marseille AGM Information	2010-04-21	French
Innate Pharma (Euronext Paris: FR0010331421 – IPH) to hold its Annual General Meeting of Shareholders on May 25, 2010, in Marseilles, France AGM Information	2010-04-21	English
Innate Pharma SA publie le nombre d'actions composant son capital social ainsi que le nombre de droits de vote associés au 31 mars 2010 Share Issue/Capital Change	2010-04-08	French
Innate Pharma SA has released the total number of shares outstanding and voting rights, as of March 31, 2010. Share Issue/Capital Change	2010-04-08	English
Innate Pharma (the “Company” - Euronext Paris: FR0010331421 – IPH) today updates on it next meetings with analysts and investors Investor Presentation	2010-04-07	English
Innate Pharma SA (la « Société » - Euronext Paris : FR0010331421 – IPH) fait le point sur ses prochains RDV avec la communauté financière Investor Presentation	2010-04-07	French
Innate Pharma SA (Euronext Paris : FR0010331421 – IPH) annonce aujourd’hui ses résultats financiers pour 2009 et fait le point sur ses produits en développement Earnings Release FY 2009	2010-03-05	French
Innate Pharma (Euronext Paris: FR0010331421 – IPH) reports today its consolidated financial results for the year ending December 31, 2009 and updates on its drug candidates Earnings Release FY 2009	2010-03-05	English
Innate Pharma SA (Euronext Paris: FR0010331421 – IPH) announces an operating revenue of 7.7 million euros for the year 2009. Earnings Release FY 2009	2010-02-05	English
Innate Pharma SA (Euronext Paris : FR0010331421 – IPH) annonce des produits opérationnels de 7,7 millions d’euros en 2009 Earnings Release FY 2009	2010-02-05	French
Nouveau nombre d’actions et de droits de vote et situation de trésorerie d’INNATE PHARMA au 31 décembre 2009 Share Issue/Capital Change	2010-01-08	French
Number of shares and voting rights and cash situation of INNATE PHARMA as at December 31, 2009 Share Issue/Capital Change	2010-01-08	English
Bilan semestriel du contrat de liquidité INNATE PHARMA avec la société NATIXIS SECURITIES Regulatory Filings	2010-01-08	French
Half-year report on INNATE PHARMA’S liquidity contract with NATIXIS SECURITIES Capital/Financing Update	2010-01-08	English

Filings by year

2026 40 filings
2025 135 filings
2024 136 filings
2023 150 filings
2022 124 filings
2021 123 filings
2020 67 filings
2019 127 filings
2018 50 filings
2017 50 filings
2016 74 filings
2015 51 filings
2014 55 filings
2013 37 filings
2012 46 filings
2011 38 filings
2010 41 filings
2009 50 filings
2008 9 filings